| Primary information |
|---|
| sequence ID | Seq_5568 |
| Peptide sequence | NDNEEGFFSAR |
| CancerPDF_ID | CancerPDF_ID162, CancerPDF_ID863, CancerPDF_ID2758, |
| PMID | 19728888,19795908,21136997 |
| Protein Name | Fibrinopeptide B,Fibrinogen beta chain,Fibrinogen beta chain |
| UniprotKB Entry Name | FIBB_HUMAN,FIBB_HUMAN,FIBB_HUMAN |
| Fluid | Serum,Plasma,Plasma |
| M/Z | 1129.4849,643.27,1284.5371 |
| Charge | NA,2,1 |
| Mass (in Da) | NA,NA,NA |
| fdr | NA,NA,NA |
| Profiling Technique | MALDI-TOF,LC-MS,LC-MS |
| Peptide Identification technique | LC-MS/MS,MALDI-TOF/TOF,LC-MS-MS/MS |
| Quantification Technique | NA,LC-MRM (multiple reaction monitoring),LC-ESI-MS |
| Labelled/Label Free | Label Free,Labelled,Label Free |
| FDR | NA,less than 7%,NA |
| CancerPDF_ID | CancerPDF_ID162, CancerPDF_ID863, CancerPDF_ID2758, |
| p-Value | less than 0.01,NA,NA |
| Software | MASCOT(v 2.0.04 for Windows),FlexAnalysis 3.0 and Biotools 3.0 software,MASCOT(v. 2.2.01) |
| Length | 11,11,11 |
| Cancer Type | "Non-small cell lung cancer (NSCLC) patients, who were treated with first-line chemotherapy",Ductal adenocarcinoma of the pancreas (DAP),Normal |
| Database | SwissProt Database (release 54.7),NCBI refseq Protein Database,SwissProt Database |
| Modification | NA,NA,NA |
| Number of Patients | "11 NSCLC patients with the shortest PFS, 11 patients with the longest PFS","42 normal, 26 patients",27 healthy individuals |
| Regulation | Peptide Ion Signature for differentiation between Short PFS(Progression Free survival) versus long PFS,NA,NA |
| Validation | Independent validation,NA,Leave One out Cross validation |
| Sensitivity | 1,NA,NA |
| Specificity | 0.73,NA,NA |
| Accuracy | 0.86,NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |